Beam Therapeutics Inc.
BEAM
$15.47
$0.845.74%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 63.52M | 349.64M | 352.57M | 360.91M | 377.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 63.52M | 349.64M | 352.57M | 360.91M | 377.71M |
| Cost of Revenue | 367.56M | 406.19M | 411.99M | 422.55M | 437.38M |
| Gross Profit | -304.04M | -56.55M | -59.42M | -61.64M | -59.67M |
| SG&A Expenses | 111.53M | 126.12M | 125.02M | 120.05M | 116.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 479.09M | 532.32M | 537.00M | 542.60M | 554.19M |
| Operating Income | -415.57M | -182.67M | -184.44M | -181.69M | -176.49M |
| Income Before Tax | -376.70M | -142.19M | -141.61M | -133.37M | -131.16M |
| Income Tax Expenses | 39.00K | 1.41M | 1.41M | 1.37M | 1.37M |
| Earnings from Continuing Operations | -376.74 | -143.59 | -143.01 | -134.74 | -132.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -376.74M | -143.59M | -143.01M | -134.74M | -132.53M |
| EBIT | -415.57M | -182.67M | -184.44M | -181.69M | -176.49M |
| EBITDA | -393.64M | -160.83M | -162.88M | -160.89M | -156.47M |
| EPS Basic | -4.58 | -1.72 | -1.76 | -1.74 | -1.87 |
| Normalized Basic EPS | -2.77 | -0.99 | -0.99 | -1.09 | -1.08 |
| EPS Diluted | -4.58 | -1.76 | -1.81 | -1.78 | -1.91 |
| Normalized Diluted EPS | -2.77 | -1.01 | -1.01 | -1.11 | -1.10 |
| Average Basic Shares Outstanding | 329.25M | 327.28M | 323.89M | 317.92M | 308.49M |
| Average Diluted Shares Outstanding | 329.25M | 329.12M | 325.74M | 319.76M | 310.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
